NZ566020A - Prion-specific peptoid reagents - Google Patents
Prion-specific peptoid reagentsInfo
- Publication number
- NZ566020A NZ566020A NZ566020A NZ56602006A NZ566020A NZ 566020 A NZ566020 A NZ 566020A NZ 566020 A NZ566020 A NZ 566020A NZ 56602006 A NZ56602006 A NZ 56602006A NZ 566020 A NZ566020 A NZ 566020A
- Authority
- NZ
- New Zealand
- Prior art keywords
- glycine
- seq
- aminobutyl
- phenylethyl
- amino acid
- Prior art date
Links
- 108010043958 Peptoids Proteins 0.000 title abstract 5
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 3
- 102000029797 Prion Human genes 0.000 title 1
- 108091000054 Prion Proteins 0.000 title 1
- 108010000652 (S)-N-(1-phenylethyl)glycine Proteins 0.000 abstract 4
- OGAULEBSQQMUKP-UHFFFAOYSA-N 2-(4-aminobutylamino)acetic acid Chemical group NCCCCNCC(O)=O OGAULEBSQQMUKP-UHFFFAOYSA-N 0.000 abstract 4
- RFEBVEWGRABHPU-QMMMGPOBSA-N 2-[[(1s)-1-phenylethyl]azaniumyl]acetate Chemical group OC(=O)CN[C@@H](C)C1=CC=CC=C1 RFEBVEWGRABHPU-QMMMGPOBSA-N 0.000 abstract 4
- 150000001413 amino acids Chemical class 0.000 abstract 3
- KGSVNOLLROCJQM-UHFFFAOYSA-N 2-(benzylamino)acetic acid Chemical group OC(=O)CNCC1=CC=CC=C1 KGSVNOLLROCJQM-UHFFFAOYSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 125000005647 linker group Chemical group 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71576105P | 2005-09-09 | 2005-09-09 | |
| US72668605P | 2005-10-14 | 2005-10-14 | |
| US75893406P | 2006-01-13 | 2006-01-13 | |
| PCT/US2006/035226 WO2007030804A1 (en) | 2005-09-09 | 2006-09-08 | Prion-specific peptoid reagents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ566020A true NZ566020A (en) | 2012-08-31 |
Family
ID=37651167
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ566020A NZ566020A (en) | 2005-09-09 | 2006-09-08 | Prion-specific peptoid reagents |
| NZ594844A NZ594844A (en) | 2005-09-09 | 2006-09-08 | Prion-specific peptoid reagents |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ594844A NZ594844A (en) | 2005-09-09 | 2006-09-08 | Prion-specific peptoid reagents |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7834144B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1931695B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5209477B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080048527A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101356186A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006287299B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0615618A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2621767A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1931695T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2404940T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL189992A0 (cg-RX-API-DMAC7.html) |
| NZ (2) | NZ566020A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007030804A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200802186B (cg-RX-API-DMAC7.html) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060035242A1 (en) * | 2004-08-13 | 2006-02-16 | Michelitsch Melissa D | Prion-specific peptide reagents |
| WO2006076497A2 (en) * | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Osplation of pathogenic prions |
| WO2006076683A2 (en) * | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Isolation and detection of pathogenic prions |
| WO2007030804A1 (en) | 2005-09-09 | 2007-03-15 | Novartis Ag | Prion-specific peptoid reagents |
| FR2892820B1 (fr) * | 2005-11-03 | 2008-02-01 | Diagast Soc Par Actions Simpli | Procede magnetique d'immunodiagnostic pour la mise en evidence de complexe anticorps/antigene, en particulier de groupe sanguin |
| CA2678967C (en) * | 2007-02-23 | 2013-10-01 | The Research Foundation Of State University Of New York | Rna targeting compounds and methods for making and using same |
| US9260476B2 (en) | 2007-02-23 | 2016-02-16 | The Research Foundation For The State University Of New York | RNA targeting compounds and methods for making and using same |
| EP2140272A1 (en) * | 2007-04-04 | 2010-01-06 | Novartis Ag | Prion elisa |
| JP2010523977A (ja) * | 2007-04-04 | 2010-07-15 | ノバルティス アーゲー | プリオンアッセイ |
| JP5400050B2 (ja) * | 2007-10-02 | 2014-01-29 | シーエスエル、リミテッド | 治療用抗体の精製法および使用法 |
| US8445632B2 (en) * | 2008-02-08 | 2013-05-21 | The Regents Of The University Of California | Selective poly-N-substituted glycine antibiotics |
| JP2011520108A (ja) * | 2008-04-30 | 2011-07-14 | ノバルティス アーゲー | 病原性配座異性体についてのアッセイ |
| WO2010017412A1 (en) * | 2008-08-06 | 2010-02-11 | The Regents Of The University Of California | Novel biomimetic peptoid polymers |
| WO2010098843A2 (en) | 2009-02-24 | 2010-09-02 | New York University | Peptoid oligomers, pharmaceutical compositions and methods of using the same |
| CN102439451B (zh) | 2009-06-02 | 2014-12-03 | 德克萨斯大学系统董事会 | 患神经退行性疾病的对象中抗体所识别的小分子的鉴定 |
| CN102725639A (zh) * | 2009-11-04 | 2012-10-10 | 诺华有限公司 | 蛋白质聚集物与单体分离中作为结合试剂的带正电物质 |
| US8952127B2 (en) | 2010-06-04 | 2015-02-10 | The Regents Of The University Of California | Peptoids useful for catalyzing the mineralization of calcium carbonate |
| WO2013043669A1 (en) * | 2011-09-21 | 2013-03-28 | The Board Of Regents Of The University Of Texas System | Peptoid compositions for the treatment of alzheimer's disease and polyglutamine expansion disorder |
| WO2014025785A2 (en) * | 2012-08-06 | 2014-02-13 | Trustees Of Boston University | Prion protein ligands as therapeutic agents for neurodegenerative disorders |
| US9764953B2 (en) | 2013-03-20 | 2017-09-19 | The Regents Of The University Of California | Peptoids useful for the mineralization of apatite |
| WO2016145286A1 (en) | 2015-03-11 | 2016-09-15 | Lumos Pharma, Inc. | Synthesis of cyclocreatine and analogs thereof |
| WO2017066454A2 (en) | 2015-10-14 | 2017-04-20 | X-Therma, Inc. | Compositions and methods for reducing ice crystal formation |
| JP7026643B2 (ja) * | 2016-03-09 | 2022-02-28 | マイク-アン、エルエルシー | ペプトイド親和性リガンド |
| JP7212373B2 (ja) | 2017-04-12 | 2023-01-25 | エックス-サーマ インコーポレイテッド | 新規ペプトイドポリマーおよび使用方法 |
| EP3894380A4 (en) | 2018-12-10 | 2022-05-04 | Provivi, Inc. | SYNTHESIS OF CONJUGATED DIENE PHEROMONES AND RELATED COMPOUNDS |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806627A (en) | 1987-05-29 | 1989-02-21 | Research Foundation Of Mental Hygiene Inc. | Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
| US5811387A (en) | 1990-05-15 | 1998-09-22 | Chiron Corporation | Peptoid mixtures |
| IE66205B1 (en) * | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
| AU8337291A (en) | 1990-08-06 | 1992-03-02 | Cetus Corporation | Methods for the identification of cytokine convertase inhibitors |
| WO1993011155A1 (en) | 1991-12-03 | 1993-06-10 | Proteus Molecular Design Limited | Fragments of prion proteins |
| WO1993023432A1 (en) | 1992-05-15 | 1993-11-25 | New York University | Soluble prion polypeptides, and methods for detecting and purifying thereof |
| US5831005A (en) | 1992-09-24 | 1998-11-03 | Chiron Corporation | Synthesis of N-substituted oligomers |
| US5877278A (en) | 1992-09-24 | 1999-03-02 | Chiron Corporation | Synthesis of N-substituted oligomers |
| PL308204A1 (en) | 1992-09-24 | 1995-07-24 | Chiron Corp | Synthesis of n-substituted oligomers |
| US5948763A (en) | 1995-06-07 | 1999-09-07 | New York University | Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
| EP1416280A3 (en) | 1995-09-14 | 2005-08-10 | The Regents of the University of California | Antibodies specific for native PrPsc |
| US5750361A (en) | 1995-11-02 | 1998-05-12 | The Regents Of The University Of California | Formation and use of prion protein (PRP) complexes |
| US5695005A (en) | 1995-12-28 | 1997-12-09 | Chen; Chia-Hsien | Fluid dynamic crossflow cooling tower |
| AU713529B2 (en) | 1996-04-03 | 1999-12-02 | Stichting Dienst Landbouwkundig Onderzoek | Method for the detection of prion diseases |
| US6586193B2 (en) | 1996-04-25 | 2003-07-01 | Genicon Sciences Corporation | Analyte assay using particulate labels |
| EP0941122B1 (en) | 1996-08-13 | 2003-10-29 | Chiron Corporation | Compositions for polynucleotide delivery |
| WO1998035236A2 (en) | 1997-02-06 | 1998-08-13 | Enfer Technology Limited | Immunological assay for spongiform encephalopathies |
| EP0861900A1 (en) | 1997-02-21 | 1998-09-02 | Erziehungsdirektion Of The Canton Zurich | Immunological detection of prions |
| US7005295B1 (en) | 1997-04-16 | 2006-02-28 | Wyeth | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| US6787319B2 (en) | 1997-04-16 | 2004-09-07 | American Home Products Corp. | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| US6033631A (en) | 1997-04-28 | 2000-03-07 | Chiron Corporation | Synthesizer with reagent recycling |
| DE19741607A1 (de) | 1997-09-20 | 1999-03-25 | Prionics Ag | Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen |
| US6165784A (en) | 1997-10-14 | 2000-12-26 | The United States Of America As Represented By The Secretary Of Agriculture | Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies |
| AU3642499A (en) | 1998-04-14 | 1999-11-01 | Sugen, Inc. | Ste20-related protein kinases |
| US6211149B1 (en) | 1998-08-03 | 2001-04-03 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors of formation of protease resistant prion protein |
| US6528269B1 (en) | 1998-06-22 | 2003-03-04 | Case Western Reserve University | Immunological agents specific for prion protein (PRP) |
| FI982480A0 (fi) | 1998-11-17 | 1998-11-17 | Wallac Oy | Immunomääritys nisäkkäiden tarttuvan spongiomuotoisen aivotaudin määrittämiseksi |
| JP5122705B2 (ja) | 1999-01-25 | 2013-01-16 | ミナーヴァ・バイオテクノロジーズ・コーポレーション | 神経変性疾患における異常型タンパク質凝集の迅速かつ高感度の検出 |
| US6551843B1 (en) | 1999-01-29 | 2003-04-22 | Immunivest Corporation | Methods for enhancing binding interactions between members of specific binding pairs |
| ES2278617T3 (es) | 1999-06-23 | 2007-08-16 | Idexx Laboratories Inc | Peptidos de proteinas de prion y sus usos. |
| US6261790B1 (en) | 1999-07-15 | 2001-07-17 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| BR0012765A (pt) | 1999-07-27 | 2002-04-02 | Imp College Innovations Ltd | Peptìdeo, métodos de fabricar um anticorpo, de fabricar um agente de ligação capaz de ligar-se a uma forma celular de uma proteìna de prion, de remover uma forma celular de uma proteìna de prion de uma amostra, e de usar um anticorpo e/ou agente de ligação, anticorpo, agente de ligação, uso de um anticorpo ou agente de ligação, kit, e , sequência de peptìdeo de uma forma celular de uma proteìna de prion |
| JP2003514773A (ja) | 1999-09-28 | 2003-04-22 | ウニヴェルジテート チューリッヒ | 血清及び血漿中のプリオン結合活性を有する因子並びに伝染性海綿状脳障害を検出するための薬剤 |
| FR2801106B1 (fr) | 1999-11-12 | 2007-10-05 | Commissariat Energie Atomique | Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc |
| EP1267904A4 (en) * | 2000-02-16 | 2006-02-08 | Univ Northwestern | POLYPEPTOIDE PULMONARY SURFACTANTS |
| CA2405568A1 (en) | 2000-04-05 | 2001-10-18 | North Carolina State University | Prion-binding peptidic ligands and methods of using same |
| IL148202A0 (en) | 2000-06-20 | 2002-09-12 | Caprion Pharmaceuticals Inc | Copolymers and methods of treating prion-related diseases |
| RS51523B (sr) | 2000-07-07 | 2011-06-30 | Laboratoires Serono Sa. | Rana dijagnoza konformacionih bolesti |
| US6537548B1 (en) | 2000-07-27 | 2003-03-25 | The Regents Of The University Of California | Antibodies specific for ungulate PrP |
| US20030092613A1 (en) | 2000-08-14 | 2003-05-15 | Lee Daniel H. S. | Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides |
| ES2300379T3 (es) * | 2000-12-23 | 2008-06-16 | Novartis Vaccines And Diagnostics, Inc. | Procedimiento de deteccion selectiva de transfeccion de oligonucleotidos. |
| GB0103508D0 (en) | 2001-02-13 | 2001-03-28 | Univ Dundee | Screening method and agents |
| US20050026165A1 (en) | 2001-05-31 | 2005-02-03 | Cindy Orser | Detection of conformationally altered proteins and prions |
| AU2002320045B2 (en) | 2001-05-31 | 2008-05-08 | Adlyfe, Inc. | Misfolded protein sensor method |
| EP1333708A4 (en) | 2001-07-19 | 2008-08-13 | Toray Industries | CIRCUIT BOARD, CIRCUIT BOARD USAGE MEMBER AND CORRESPONDING PRODUCTION METHOD, AND SOFT FILM STRATIFICATION METHOD |
| EP1572894B1 (en) | 2001-11-21 | 2016-04-13 | New York University | Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto |
| CA2467914A1 (en) | 2001-12-10 | 2003-06-19 | Applied Research Systems Ars Holding N.V. | Prion inhibiting peptides and derivatives thereof |
| US20040052928A1 (en) | 2002-09-06 | 2004-03-18 | Ehud Gazit | Peptides and methods using same for diagnosing and treating amyloid-associated diseases |
| CA2475247C (en) * | 2002-02-07 | 2015-08-04 | Massachusetts Institute Of Technology | Anti-pathogen treatments |
| ES2564293T5 (es) | 2002-02-28 | 2019-04-04 | Microsens Biophage Ltd | Enlazamiento de formas patológicas de proteínas priónicas |
| WO2003085086A2 (en) | 2002-04-09 | 2003-10-16 | The Scripps Research Institute | Motif-grafted hybrid polypeptides and uses thereof |
| US20040208919A1 (en) | 2002-06-13 | 2004-10-21 | Nicolau Yves C. | Vaccination against prion diseases |
| DE10230141B4 (de) | 2002-07-04 | 2004-07-15 | Priontype Gmbh | Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) |
| EP1382971A1 (en) | 2002-07-17 | 2004-01-21 | Pepscan Systems B.V. | Detection of prion disease |
| EP1534746A2 (en) | 2002-08-23 | 2005-06-01 | Copenhagen Biotech Assets APS | Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| US20040072236A1 (en) | 2002-09-27 | 2004-04-15 | Neil Cashman | PrPSc -interacting molecules and uses thereof |
| AU2003265504A1 (en) | 2002-10-10 | 2004-05-04 | Heinrich Heine University Of Dusseldorf | Use of monoclonal antibodies to distinguish protein conformational isoforms |
| ES2283608T3 (es) | 2002-10-23 | 2007-11-01 | Centre For Research And Technology Hellas/Institute Of Agrobiotechnology In.A | Secuencias peptidicas de union a la proteina prionica. |
| AU2002352042A1 (en) | 2002-11-18 | 2004-06-15 | Prionics Ag | Method for the detection of prpsc |
| ES2527408T3 (es) | 2002-12-03 | 2015-01-23 | North Carolina State University | Ligandos de proteínas priones y procedimientos de uso |
| EP1457500A1 (en) | 2003-03-14 | 2004-09-15 | University of Zurich | Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| JP4783727B2 (ja) | 2003-04-04 | 2011-09-28 | パソゲン リムーバル アンド ダイアグノスティック テクノロジーズ インコーポレーテッド | プリオンタンパク質結合物質と使用法 |
| WO2004092197A2 (en) | 2003-04-07 | 2004-10-28 | The Regents Of The University Of California | Amyloid-specific peptides and uses thereof |
| JP2006524340A (ja) | 2003-04-14 | 2006-10-26 | アメリカン ナショナル レッド クロス | タンパク質の構造アイソフォームに特異的なリガンドを特定するための方法 |
| ES2398394T3 (es) | 2003-08-13 | 2013-03-15 | Novartis Vaccines And Diagnostics, Inc. | Reactivos peptídicos específicos de prión |
| US20060035242A1 (en) | 2004-08-13 | 2006-02-16 | Michelitsch Melissa D | Prion-specific peptide reagents |
| JP3910569B2 (ja) | 2003-08-19 | 2007-04-25 | 独立行政法人科学技術振興機構 | アミロイドβ蛋白質のアミロイド線維化を増幅するための試薬 |
| AU2004305111B2 (en) * | 2003-12-19 | 2011-04-28 | Novartis Vaccines And Diagnostics, Inc. | Cell transfecting formulations of small interfering RNA, related compositions and methods of making and use |
| SE0400274D0 (sv) | 2004-02-09 | 2004-02-09 | Affibody Ab | New polypeptide |
| JP4773697B2 (ja) | 2004-06-30 | 2011-09-14 | ルネサスエレクトロニクス株式会社 | Soi基板およびその製造方法ならびに半導体装置 |
| DE102004043782A1 (de) | 2004-09-08 | 2006-03-09 | Heinrich-Heine-Universität Düsseldorf | Polypeptide und Verfahren zur spezifischen Bindung von Prionen |
| US20060057671A1 (en) | 2004-09-10 | 2006-03-16 | Orser Cindy S | Immobilized probes and methods of detecting conformationally altered prion proteins |
| AU2005209592B2 (en) | 2004-09-30 | 2012-07-12 | Ortho-Clinical Diagnostics, Inc. | Peptides for discrimination of prions |
| US7482172B2 (en) | 2005-09-19 | 2009-01-27 | Ortho-Clinical Diagnostics, Inc. | Peptides for discrimination of prions |
| WO2006076497A2 (en) | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Osplation of pathogenic prions |
| US20090130774A1 (en) | 2005-01-13 | 2009-05-21 | David Peretz | Elisa assays using prion-specific peptide reagents |
| EP1853915B1 (en) | 2005-02-15 | 2011-10-12 | Adlyfe, Inc. | Method for detecting misfolded proteins and prions |
| GB0503434D0 (en) | 2005-02-18 | 2005-03-30 | Senexis Ltd | Amyloid-binding peptides, analogues and uses thereof |
| WO2007030804A1 (en) | 2005-09-09 | 2007-03-15 | Novartis Ag | Prion-specific peptoid reagents |
| WO2007145589A1 (en) | 2006-06-15 | 2007-12-21 | Per Arvidsson | Peptides that are capable of binding to amyloid-beta peptide. |
| JP5097206B2 (ja) | 2006-07-28 | 2012-12-12 | エイディーライフ インコーポレイティッド | 診断および治療のためのペプチドプローブ |
| EP2152744A4 (en) | 2007-04-26 | 2012-02-15 | Univ Yale | PRION PROTEIN AS RECEPTOR FOR AMYLOID-BETA OLIGOMERS |
-
2006
- 2006-09-08 WO PCT/US2006/035226 patent/WO2007030804A1/en not_active Ceased
- 2006-09-08 ES ES06814415T patent/ES2404940T3/es active Active
- 2006-09-08 CN CNA2006800331296A patent/CN101356186A/zh active Pending
- 2006-09-08 DK DK06814415.3T patent/DK1931695T3/da active
- 2006-09-08 US US11/518,091 patent/US7834144B2/en not_active Expired - Fee Related
- 2006-09-08 NZ NZ566020A patent/NZ566020A/xx not_active IP Right Cessation
- 2006-09-08 JP JP2008530008A patent/JP5209477B2/ja not_active Expired - Fee Related
- 2006-09-08 AU AU2006287299A patent/AU2006287299B2/en not_active Ceased
- 2006-09-08 NZ NZ594844A patent/NZ594844A/xx not_active IP Right Cessation
- 2006-09-08 CA CA002621767A patent/CA2621767A1/en not_active Abandoned
- 2006-09-08 EP EP06814415.3A patent/EP1931695B1/en not_active Not-in-force
- 2006-09-08 EP EP20110171585 patent/EP2383281A3/en not_active Withdrawn
- 2006-09-08 BR BRPI0615618-5A patent/BRPI0615618A2/pt not_active IP Right Cessation
- 2006-09-08 KR KR1020087008427A patent/KR20080048527A/ko not_active Abandoned
-
2008
- 2008-03-06 IL IL189992A patent/IL189992A0/en unknown
- 2008-03-07 ZA ZA200802186A patent/ZA200802186B/xx unknown
-
2010
- 2010-10-07 US US12/924,872 patent/US20120027677A1/en not_active Abandoned
-
2012
- 2012-06-01 JP JP2012126346A patent/JP2012162571A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2383281A2 (en) | 2011-11-02 |
| KR20080048527A (ko) | 2008-06-02 |
| EP1931695B1 (en) | 2013-04-10 |
| ZA200802186B (en) | 2008-12-31 |
| WO2007030804A1 (en) | 2007-03-15 |
| NZ594844A (en) | 2013-04-26 |
| BRPI0615618A2 (pt) | 2011-05-24 |
| ES2404940T3 (es) | 2013-05-29 |
| CA2621767A1 (en) | 2007-03-15 |
| US20120027677A1 (en) | 2012-02-02 |
| US20070087972A1 (en) | 2007-04-19 |
| EP1931695A1 (en) | 2008-06-18 |
| JP5209477B2 (ja) | 2013-06-12 |
| US7834144B2 (en) | 2010-11-16 |
| JP2009507833A (ja) | 2009-02-26 |
| IL189992A0 (en) | 2008-08-07 |
| DK1931695T3 (da) | 2013-07-01 |
| EP2383281A3 (en) | 2012-01-04 |
| CN101356186A (zh) | 2009-01-28 |
| AU2006287299B2 (en) | 2012-08-23 |
| JP2012162571A (ja) | 2012-08-30 |
| AU2006287299A1 (en) | 2007-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002248147B2 (en) | Hepatitis C tripeptide inhibitors | |
| NZ594844A (en) | Prion-specific peptoid reagents | |
| AU2024202618A1 (en) | Bicyclic peptide ligands specific for EphA2 | |
| US7122627B2 (en) | Lactam inhibitors of Hepatitis C virus NS3 protease | |
| WO1999064442A1 (en) | Peptide inhibitors of hepatitis c virus ns3 protease | |
| CA2376961A1 (en) | Lactam inhibitors of hepatitis c virus ns3 protease | |
| US11713338B2 (en) | Cyclic peptides multimers targeting α-4-β-7 integrin | |
| IL180727A (en) | Antifungal peptides containing motif including arginine and / or lysine | |
| US12129222B2 (en) | Production of bitter principle derivatives | |
| JP7641895B2 (ja) | 液相ペプチド合成のための方法およびその保護戦略 | |
| WO2006087550A8 (en) | Amyloid-binding peptides, analogues and uses thereof | |
| Mhidia et al. | Exploration of an imide capture/N, N-acyl shift sequence for asparagine native peptide bond formation | |
| ES3034689T3 (en) | Synthesis of amanin and its derivatives | |
| EP0948523A1 (en) | Peptidomimetic inhibitors of the human cytomegalovirus protease | |
| Hughes et al. | Effective Methods for the Synthesis of N‐Methyl β‐Amino Acids from All Twenty Common α‐Amino Acids Using 1, 3‐Oxazolidin‐5‐ones and 1, 3‐Oxazinan‐6‐ones | |
| Nair et al. | Formation of a pseudo-β-hairpin motif utilizing the Ant–Pro reverse turn: consequences of stereochemical reordering | |
| Schmittberger et al. | Synthesis of the palmitoylated and prenylated C-terminal lipopeptides of the human R-and N-Ras proteins | |
| CN101970454A (zh) | 修饰肽的方法 | |
| ES2280566T3 (es) | Macrociclos antibacterianos. | |
| Hamzé et al. | Solid-phase synthesis of arginine-containing peptides and fluorogenic substrates using a side-chain anchoring approach | |
| DE602005025141D1 (de) | In Zellen eindringende Peptide als Träger für Moleküle | |
| JP2010523598A5 (cg-RX-API-DMAC7.html) | ||
| ES2412483T3 (es) | Derivados antibióticos de binaftilo | |
| Baker et al. | Novel reagents and reactions for drug design | |
| ATE298347T1 (de) | Immunodiagnostischer wirkstoff zum nachweiss von maedi-visna virus und caev infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 08 SEP 2013 BY FB RICE Effective date: 20130205 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 08 SEP 2016 BY CPA GLOBAL Effective date: 20130308 |
|
| ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 890887, NOVARTIS AG, LICHTSTRASSE 35, CH-4056 BASEL, CH Effective date: 20140409 |
|
| LAPS | Patent lapsed |